Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la ...

Jean-Paul Kress to join Sanofi's Board of Directors Paris, . Sanofi's Board of Directors is pleased to welcome Jean-Paul Kress as an independent director as of January 1, ...

Sepsis is a life-threatening condition that happens when the body’s immune system has an extreme response to an infection.

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the ...

Sanofi announced today that its Q4 2024 Aide-mémoire is available on the "Investors" page of the company's website: ...

Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Designation is based on positive results from the HERCULES study in adults ...

Many symptoms of MS are visible to the outside world, such as movement or speech problems, but there are also invisible symptoms (unseen by others) that significantly impact the lives of those living ...

De nombreux symptômes de la sclérose en plaques (SEP) sont visibles, comme les problèmes de mouvement ou de parole, mais il existe aussi des symptômes invisibles qui impactent considérablement la vie ...

ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients New analysis from the IMROZ phase 3 study of Sarclisa-VRd demonstrated higher and ...

Autoimmune type 1 diabetes (T1D) is an autoimmune progressive and lifelong condition that can develop regardless of age, lifestyle or family history. Individuals with autoimmune T1D are typically ...

Alizée: Lors de mon bilan de santé annuel, mon médecin a remarqué que mon taux de glycémie était légèrement plus élevé qu'il ne devrait l'être. Heureusement, il n'y avait pas de raison immédiate de ...